• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Relevium Reports Revenue Growth in the First 50 Days of Business

    Bryan Mc Govern
    Aug. 02, 2017 09:32AM PST
    Biotech Investing

    Relevium Technologies provided shareholders with a look at the company’s business in their first day of business and their strategy moving forward.

    Relevium Technologies (TSXV:RLV) provided shareholders with a look at the company’s business in their first day of business and their strategy moving forward.
    As quoted in the press release:

    On June 6, 2017, Relevium acquired the assets and business of BioGanix, the Company’s first acquisition of e-retail assets. Management and the previous owner of BioGanix have been working diligently to ensure a smooth transition of the business. Jointly, careful detailed transitioning of the online operations has been ongoing in order to avoid any possible disruptions to the daily business operations.
    The Company is happy to announce that the initial transition of the current business has been successful, and Relevium has recorded revenues of approximately CAD$700,000 since closing, representing a 52% increase over the previous period last year (47% increase taking into account the effect of FX fluctuations).
    In the month of August, management will be working closely with the previous ownership to optimize operations and making additions to the current product offering.
    Aurelio Useche, CEO, stated: “We are extremely pleased with the dedication and professionalism demonstrated by the previous ownership, the staff and our internal team during this initial phase of work.” Mr. Useche continued: “We look forward to this continued partnership as we move into the optimization phase of the transition.”

    Click here to read the full press release.

    Source: www.marketwired.com

    The Conversation (0)

    Go Deeper

    AI Powered
    Tech Outlook: Australia Edition

    Tech Outlook: Australia Edition

    Relevium Technologies

    Relevium Technologies

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×